The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALKERMES PLC SHS G01767105   148,512,000 4,200,000 SH   SOLE   4,200,000 0 0
ALTO NEUROSCIENCE INC COM SHS 02157Q109   61,217,446 2,723,196 SH   SOLE   2,723,196 0 0
AMYLYX PHARMACEUTICALS INC COM 03237H101   78,535,000 5,650,000 SH   SOLE   5,650,000 0 0
AN2 THERAPEUTICS INC COM 037326105   7,981,298 2,333,713 SH   SOLE   2,333,713 0 0
ASSEMBLY BIOSCIENCES INC COM NEW 045396207   27,750,000 1,000,000 SH   SOLE   1,000,000 0 0
AVALO THERAPEUTICS INC COM NEW 05338F306   7,211,190 483,000 SH   SOLE   483,000 0 0
CELLDEX THERAPEUTICS INC NEW COM NEW 15117B202   85,536,660 2,696,616 SH   SOLE   2,696,616 0 0
COGENT BIOSCIENCES INC COM 19240Q201   111,159,389 2,888,007 SH   SOLE   2,888,007 0 0
CORVUS PHARMACEUTICALS INC COM 221015100   33,045,293 2,258,735 SH   SOLE   2,258,735 0 0
DAMORA THERAPEUTICS INC COM NEW 36322Q206   50,220,100 1,939,000 SH   SOLE   1,939,000 0 0
DEFINIUM THERAPEUTICS INC COM SHS 24477V105   37,800,000 2,000,000 SH   SOLE   2,000,000 0 0
ENLIVEN THERAPEUTICS INC COM 29337E102   128,380,000 3,275,000 SH   SOLE   3,275,000 0 0
ERASCA INC COM 29479A108   51,371,500 3,175,000 SH   SOLE   3,175,000 0 0
EYEPOINT INC COM NEW 30233G209   36,414,250 2,825,000 SH   SOLE   2,825,000 0 0
HELIX ACQUISITION CORP III USD CL A ORD SHS G4444S107   5,080,000 500,000 SH   SOLE   500,000 0 0
INHIBIKASE THERAPEUTICS INC COM NEW 45719W205   9,067,780 5,397,488 SH   SOLE   5,397,488 0 0
KARYOPHARM THERAPEUTICS INC COM NEW 48576U205   10,861,500 1,950,000 SH   SOLE   1,950,000 0 0
KYMERA THERAPEUTICS INC COM 501575104   62,467,500 750,000 SH   SOLE   750,000 0 0
LB PHARMACEUTICALS INC COM SHS 50180M108   36,990,000 1,500,000 SH   SOLE   1,500,000 0 0
NURIX THERAPEUTICS INC COM 67080M103   35,262,500 2,275,000 SH   SOLE   2,275,000 0 0
NUVALENT INC COM 670703107   85,402,320 833,600 SH   SOLE   833,600 0 0
OCULAR THERAPEUTIX INC COM 67576A100   21,810,250 2,575,000 SH   SOLE   2,575,000 0 0
PALISADE BIO INC COM 696389402   12,566,859 7,181,062 SH   SOLE   7,181,062 0 0
PEPGEN INC COM 713317105   7,920,750 4,475,000 SH   SOLE   4,475,000 0 0
PERSPECTIVE THERAPEUTICS INC COM NEW 46489V302   26,424,381 6,336,782 SH   SOLE   6,336,782 0 0
PHARVARIS N V COM N69605108   54,210,903 1,918,970 SH   SOLE   1,918,970 0 0
RELAY THERAPEUTICS INC COM 75943R102   169,150,000 17,000,000 SH   SOLE   17,000,000 0 0
RELMADA THERAPEUTICS INC COM 75955J402   4,411,951 633,901 SH   SOLE   633,901 0 0
SAB BIOTHERAPEUTICS INC COM NEW 78397T202   16,857,745 4,401,500 SH   SOLE   4,401,500 0 0
SOLENO THERAPEUTICS INC COM 834203309   21,843,423 652,432 SH   SOLE   652,432 0 0
SPYRE THERAPEUTICS INC COM NEW 00773J202   96,460,447 1,912,380 SH   SOLE   1,912,380 0 0
TYRA BIOSCIENCES INC COM 90240B106   94,792,500 2,475,000 SH   SOLE   2,475,000 0 0
XENON PHARMACEUTICALS INC COM 98420N105   47,973,750 825,000 SH   SOLE   825,000 0 0
ZURA BIO LTD CLASS A ORD SHS G9TY5A101   19,337,500 3,250,000 SH   SOLE   3,250,000 0 0
CENTURY THERAPEUTICS INC COM 15673T100   19,652,174 8,695,652 SH   SOLE   8,695,652 0 0
LEONABIO INC COM 04746L203   4,774,011 464,398 SH   SOLE   464,398 0 0